Studies how genetic variations affect drug metabolism and response. PGx predict individual drug reactions (e.g., warfarin sensitivity), while custom PGx pipelines analyze key enzymes (CYP2D6, CYP2C19) and transporters (SLCO1B1) to optimize dosing and reduce adverse drug reactions (ADRs), which account for ~6.5% of hospital admissions.
Take the first step toward better health — send us your inquiry today and discover personalized insights for a healthier future.
"Frankly speaking, the experience was the first time I dealt with them. They were very quick to respond. They made an appointment for me at home on their appointment, and there was no delay. The result was not delayed exactly as they said, 7 days. God willing, I wish them success, Lord."
© Copyright 2025 Novo Genomics. All Rights Reserved